-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/gestational-diabetes-screening-diagnosis_research-protocol.pdf
December 16, 2011 - apparent during pregnancy.
1
Disappearance of GDM
postpartum is critical, as previously undiagnosed type … GDM incidence has increased over the past decades, alongside the increase in rates of
obesity and type … disagree on screening recommendations.
15
However, many practitioners have decided to adopt some type … and transient), birth injury, hypoglycemia,
hyperbilirubinemia, mortality
Long-term: obesity, type … and transient), birth injury, hypoglycemia,
hyperbilirubinemia, mortality
Long-term: obesity, type
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stem-cell-children_research-protocol.pdf
November 01, 2010 - Pediatric HSCT Indications to Be Addressed with Systematic Review
Nonmalignant Setting(s) Type Of … II
Multiple enzyme deficiency
Galactosialidosis,
Mucolipidosis type II
Lysosomal transport defects … Auto/allo Immunosuppressants,
targeted biologic therapies
and low-dose chemotherapy
Autoimmune type … Were the number and type of harmful events reported
separately for study groups?
E. … 1"[Mesh] OR ("type 1" AND (diabetes OR
diabetic OR DM)) OR "juvenile diabetes"
10:17:59 60849
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-disposition-comments.pdf
May 14, 2025 - For each
metric, there are crucial elements of context:
the cancer type, the type of study
(diagnostic … of analyte
(ctDNA, proteins, etc) and an under-
emphasis on cancer type. … I do worry that the division by type of
analyte in Figure 2 could lead some to the
conclusion that, … Thus, the type of
analyte used is likely not the primary driver of
accuracy. … of study design is much more
important than the type of analyte.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_executive.pdf
September 01, 2011 - JIA is an
important cause of chronic disease in
childhood, with prevalence similar to type I
diabetes … In children with JIA, does the rate and
type of adverse eventsf differ between the various
DMARDs or … In children with JIA, do the rate
and type of adverse events differ between:
a. … The rate and type of adverse events did not differ
between treatment groups in these studies. … The rate and
type of adverse events were generally similar
between intervention and placebo groups,
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/deliberative-methods_presentation-2013.pdf
January 01, 2013 - This type of “thought mapping” can help participants understand their own
thinking more clearly and … Next, the type of participant interaction should be considered.
9
Some online tools … This type of interaction is sometimes referred to as “synchronous
communication.” … The type of
discussion often determines which tool is most appropriate for the deliberation.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-2.pdf
June 01, 2022 - [Type of
publication (Conference abstract)]
5. Barreto T. … [Type of publication
(Conference abstract)]
9. Eli Lilly Company. … [Type of publication
(Conference abstract)]
11. Fayoum University. … [Type of publication
(Conference abstract)]
16. Kou RZ, Yang F, Lin Q, et al. … [Type of publication (Conference abstract)]
26.
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-242-radiation-therapy-brain-metastases-evidence-summary.pdf
June 01, 2021 - We did not detect consistent effects of prognosis, WBRT dose or primary tumor type
(all low SoE) but … systematic effect of SRS fractionation schedule (low SoE),
patient prognosis (low SoE), or primary tumor type … interventions and outcomes, we did not detect systematic differences in study
results based on primary tumor type … Most identified studies used mixed samples in terms of primary tumor type
and prognosis, only WBRT studies
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-substitute_0.pdf
October 03, 2019 - characteristics (such as those listed below) in each included
investigation for each chronic wound type … Inclusion/exclusion criteria of wounds including at least wound type, wound
size/depth/duration/severity … Wound characteristics of enrollees including at least wound type, wound
size/depth/duration/severity … What study variables (e.g. patient age, comorbidities, ancillary therapies, type of treatment
center … preliminary searches identify insufficient evidence (<5 randomized
controlled trials for any wound type
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-pharm-non-pharm-treatment-update-disposition-comments.pdf
August 28, 2024 - We
describe the Data
Stories associated
with the PTSD
Repository which
provide this type of
accessible … It is just difficult to understand the trauma type
(pg 22) results when the populations are combined … to categorize those
with multiple traumas
or that don’t fit into
prespecified
categories, this type … This type of tool
quantifies that need – I’m not sure that message is
readily apparent in the discussion … frequently,
we have not yet
conducted longer
term overviews of
changes over time,
though this type
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/depression-treatment-ssri_research-protocol.pdf
June 15, 2010 - therapy
Light therapy (any therapy that includes primarily exposure to light)
Exercise (any type … status, type of effect measure (endpoint or
change score, measure of variance (standard deviation, … standard error), etc), definition of
“adequate” treatment response, and type of statistical analysis … study outcomes (both of
benefit and of harm), sample size, settings, funding sources, treatments (type … We will separate studies by design type and only select like designs when meta-
analysis is indicated
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update-surveillance-160328.pdf
May 29, 2025 - Finally,"while"the"original"
review"found"no"evidence"comparing"ACEIs"or"ARBs"on"
progression"to"type"II"diabetes … ,"we"identified"one"retrospective"
cohort"study"which"found"a"lower"risk"of"type"II"diabetes"onset" … of$a$single$antihypertensive$agent$for$blood$pressure$control$
o$ Lipid$levels$
o$ Progression$to$type … In$a$
clinical$setting,$patients$initiated$on$candesartan$treatment$had$a$lower$risk$of$new"onset$type … $of$
15,900$patients$compared$ACEI$
enalapril$to$ARB$candesartan$and$
found$that$the$risk$of$new$type
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-research-report-integrating-health-system-data.pdf
April 01, 2020 - system data and possible next steps in developing processes and
capacity to routinely conduct this type … This does not appear to be
common practice, perhaps because it requires access to this type of data … .24 Based on an analysis of KPNW data showing a differential rate of progression of
prediabetes to type … processes required to
have real-time access to and ability to utilize health system data to do this type … Screening for Abnormal Glucose and Type 2
Diabetes Mellitus: A Systematic Review to
Update the 2008
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity_hi_impact.pdf
April 17, 2012 - ........................ 2
EndoBarrier endoluminal sleeve for excess weight loss and treatment of type … Lorcaserin is an investigational 5-hydroxytryptamine Type 2C (5-HT2C) receptor
agonist believed to … Experts also suggested that this could shift the type of specialist providing bariatric services from … Phentermine + Topiramate (oral, obesity/type 2
diabetes). [28 p]. … Safety and efficacy study of
EndoBarrier in subjects with type II diabetes and
obesity.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/use-telehealth-during-COVID-19-executive-summary.pdf
January 01, 2023 - 3
For clinical outcomes, the difference between telehealth and in-person care varied by
the type … For process outcomes, the difference between telehealth and in-person care varied by
the type of outcome … technologies.
4
Limitations
Included studies lacked standard information on the type
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-243-prehospital-airway-management-appendix-f-1_0.xlsx
January 01, 2016 - Outcomes evidence table
Author, Year KQ Airway Type
Intervention 1 Device Name/Description
Intervention … 1 N Analyzed
Intervention 1 Airway Type
Intervention 2 Device Name/Description
Intervention 2 N Analyzed … LMA: AOR 0.61 (95% CI 0.40 to 0.91), p=0.016 Age (≥ 65 yr), gender, ethnicity, type of case, witnessed … LMA: AOR 2.82 (95% CI 1.64 to 4.86), p<0.001 Age (≥ 65 yr), gender, ethnicity, type of case, witnessed … LMA: AOR 0.94 (95% CI 0.49 to 1.79), p=0.839 Age (≥ 65 yr), gender, ethnicity, type of case, witnessed
-
effectivehealthcare.ahrq.gov/products/diabetes-oral-drugs-safety-knowledge-gaps/research
-
effectivehealthcare.ahrq.gov/products/glycemic-control/abstract
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/fiber-intake-final-appendix-c.xlsx
January 01, 2024 - neurological or psychiatric disease; medication acting on the central nervous system; type 2 diabetes … BMI > 30 kg/m2, had taken dietary supplements, laxatives, any type of medication that could affect gut … Puhlmann 2022 RCT parallel 55 Adults, any (>= ~18) [40-75] NR 46.6 Type 2 diabetes mellitus: 100 … mellitus: 0 Type 2 diabetes mellitus: 0 . … 1 diabetes mellitus: 0 Type 2 diabetes mellitus: 0 .
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-executive-summary.pdf
May 01, 2025 - effectiveness of screening with MCSTs on the cumulative
detection of cancer overall and by cancer type … with MCSTs on the cumulative
detection of late-stage cancer (i.e., stage shift) overall and by cancer type … KQ 3: What is the accuracy of MCSTs for detection of cancer and does accuracy
vary by cancer type or
-
effectivehealthcare.ahrq.gov/sites/default/files/politi.pdf
May 29, 2025 - o Does this vary by decision type (e.g. high-‐stakes
decisions or prevention
decisions)? … o What type(s) of decision aids work best?